Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 15.4b

Steroid Avoidance Rate at Discharge, 2000 to 2009

Recipients of Living Donor Kidneys

Discharge Regimen Year of Transplant
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Total Patients 4,728 5,191 5,355 5,510 5,678 5,550 5,514 5,172 5,152 5,492
Steroids Avoided 262 464 631 1,015 1,607 1,813 2,086 2,108 2,088 2,222
Rate 5.5% 8.9% 11.8% 18.4% 28.3% 32.7% 37.8% 40.8% 40.5% 40.5%
CyA Patients 167 123 80 104 122 26 28 20 6 7
Steroids Avoided 4 8 4 10 20 6 10 3 2 1
Rate 2.4% 6.5% 5.0% 9.6% 16.4% 23.1% 35.7% 15.0% 33.3% 14.3%
Tac Patients 203 223 233 191 196 136 191 186 166 255
Steroids Avoided 30 46 87 64 67 56 111 98 90 123
Rate 14.8% 20.6% 37.3% 33.5% 34.2% 41.2% 58.1% 52.7% 54.2% 48.2%
CyA+MMF Patients 1,924 1,640 1,303 1,121 954 709 502 413 317 227
Steroids Avoided 64 66 45 111 123 111 117 114 61 33
Rate 3.3% 4.0% 3.5% 9.9% 12.9% 15.7% 23.3% 27.6% 19.2% 14.5%
Tac+MMF Patients 1,398 1,977 2,595 2,881 3,338 3,844 3,979 4,000 4,193 4,568
Steroids Avoided 73 132 262 477 1,007 1,337 1,575 1,694 1,720 1,835
Rate 5.2% 6.7% 10.1% 16.6% 30.2% 34.8% 39.6% 42.4% 41.0% 40.2%
CyA+Aza Patients 186 145 51 20 14 5 6 8 3 -
Steroids Avoided 3 2 0 1 1 1 1 7 2 -
Rate 1.6% 1.4% 0.0% 5.0% 7.1% 20.0% 16.7% 87.5% 66.7% -
Tac+Aza Patients 60 84 82 70 41 9 17 14 15 15
Steroids Avoided 5 11 6 7 6 3 7 2 4 5
Rate 8.3% 13.1% 7.3% 10.0% 14.6% 33.3% 41.2% 14.3% 26.7% 33.3%
CyA+Siro Patients 260 170 142 168 129 146 135 90 87 88
Steroids Avoided 1 5 30 60 81 102 112 67 60 64
Rate 0.4% 2.9% 21.1% 35.7% 62.8% 69.9% 83.0% 74.4% 69.0% 72.7%
Tac+Siro Patients 217 429 382 371 324 210 260 70 33 9
Steroids Avoided 22 103 94 115 145 78 66 29 25 6
Rate 10.1% 24.0% 24.6% 31.0% 44.8% 37.1% 25.4% 41.4% 75.8% 66.7%
Siro+MMF Patients 45 109 152 155 109 132 85 52 61 43
Steroids Avoided 12 8 6 22 26 20 16 10 14 12
Rate 26.7% 7.3% 3.9% 14.2% 23.9% 15.2% 18.8% 19.2% 23.0% 27.9%
Other Regimen Patients 268 291 335 429 451 333 311 319 271 280
Steroids Avoided 48 83 97 148 131 99 71 84 110 143
Rate 17.9% 28.5% 29.0% 34.5% 29.0% 29.7% 22.8% 26.3% 40.6% 51.1%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressive

drug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine;

Siro: Sirolimus.